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Abstract:  
This Feature Article describes our mechanistic studies in 
organocatalytic RauhutCurrier-type reactions and some 
applications in target-oriented synthesis. The developed 
approach involves the cyclization of two tethered Michael 
acceptors via dienamine intermediates and leads to highly 
functionalized cycloalkenes. The utility of these intermediates 
is further demonstrated by the synthesis of biologically 
important targets, such as optically active iridoid derivatives.  
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1 Introduction 
The development of asymmetric transformations 
exerts considerable leverage on the efficiency of 
target-oriented syntheses.2 To this end, organocatalysis 
was shown to be a powerful alternative to metal-based 
and enzymatic catalysis.3,4 Within the field, 
aminocatalysis is probably the most explored area, 
thus, a great variety of primary and secondary chiral 
amines have been applied successfully to the synthesis 
of drugs and natural products.4c,5,6 In this respect, 
enamine7 and iminium ion8 activation, have become 
an indispensable strategy in the enantioselective -9 
and -10 functionalization of carbonyl compounds. 
More recently, dienamine activation has gained 
attention for its synthetic potential.11,12 Nevertheless, 
only a small number of examples have appeared since 
the original work of Jørgensen and Hong, where the 
electrophilic reactivity of ,-unsaturated aldehydes is 
inverted by conversion into a nucleophilic species.13 
Dienamine intermediates exhibit ambivalent reactivity 
(Figure 1). Accordingly, they can be functionalized by 
suitable electrophiles in the -14 and -position.15,16 In 
addition, dienamines can be employed as an electron-
rich diene in regular DielsAlder-type reactions,17 as 
well as dienophiles in aza-DielsAlder reactions with 
inverse electron demand.18,19 
 
Figure 1 Dienamines as chemical chameleons. 
The classical RauhutCurrier (RC) reaction, also 
known as vinylogous MoritaBaylisHillman (MBH) 
reaction, involves the addition of an enolate generated 
in situ from a Michael acceptor (RC donor) to a 
second Michael acceptor (RC acceptor) (Scheme 1), 
while in the MBH reaction the acceptor is a carbonyl 
group. In the area of dienamine catalysis our group 
recently reported an -alkylation of ,-unsaturated 
aldehydes, affording RauhutCurrier-type products in 
a mechanistically distinct reaction pathway.14a 
 
Scheme 1 General scheme for MoritaBaylisHillman (MBH) and 
RauhutCurrier (RC) reactions. 
Despite the obvious utility of the RC reaction for the 
formation of new C-C bonds, only scarce examples of 
this reaction can be found in the years after its 
discovery in 1963.20,21 This is in contrast with the 
well-studied MBH reaction.22 However, the situation 
has changed in the last years, and an analysis of the 
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recent literature indicates that the RC reaction is 
gathering increasing attention from several research 
groups. 
A transannular version of the RC reaction was 
developed by Moore in 1999.23 Later Krische24 and 
Roush25 investigated the intramolecular RC reaction 
using alkyl phosphines as nucleophilic catalysts. More 
recently, Miller,26 Wu,27 Gu and Xiao,28 Sasai,29 Shi30 
and Chi31 have reported efficient enantioselective 
versions of the intramolecular RC reaction using 
nucleophilic organocatalysts (chiral phosphines or 
amines), bifunctional acid/base catalysis, or 
combinations of nucleophilic activation and hydrogen 
bonding catalysis.32,33 Further progress has been 
accomplished in the challenging intermolecular RC 
reaction via asymmetric organocatalysis.34,35 
Highly functionalized cycloalkenes are important 
synthesis targets, as they are frequent substructure in 
biologically active molecules.36 Substituted 
cyclopentenes are frequently found in the iridoid class 
of natural products,37 which are widely distributed 
among plants and insects (Figure 2).38 In plants, 
iridoid glucosides are of particular interest as some of 
them exhibit pharmacological activity, while others 
are intermediates in the biosynthesis of alkaloids.39  
 
Figure 2 Selected iridoids from insect defensive secretions. 
There is evidence for the involvement of the RC 
reaction in the biosynthesis of natural products such as 
spinosyn A, a tetracyclic polyketide-derived 
insecticide from Saccharopolyspora spinosa. The 
enzyme SpnL was identified as responsible for the 
final cross-bridging step that completes the tetracyclic 
core of spinosyn A in a manner consistent with a 
Rauhut–Currier reaction.40 RC-type processes can be 
also invoked to explain the biosynthetic formation of 
some iridoid monoterpenes in insects, such as 
chrysomelidial (Scheme 2).41 A possible biosynthetic 
pathway suggests the formation of a dienamine 
intermediate that could be formed by condensation of 
an aldehyde function with an amino group of an 
enzyme. This intermediate could undergo an inverse 
electron-demand hetero DielsAlder reaction 
providing the cis-fused plagiodial skeleton. 
Hydrolysis and isomerization then leads to plagiodial 
and chrysomelidial, respectively. 
 
Scheme 2 Mechanistic hypothesis for the biosynthesis of 
plagiodial and chrysomelidial in insects. 
Herein, we report our recent advances in the 
development of a mechanistically distinct 
RauhutCurrier reaction using dienamine 
activation.14a Additional experiments confirm the 
important role of the -methyl group on the substrates. 
Mechanistic studies also provided insight into the 
potential mechanism proposed for this reaction. The 
novelty, operational simplicity and the applicability to 
the synthesis of optically active iridoid derivatives as 
biologically relevant targets, renders this methodology 
a useful addition to conventional RC protocols. 
As described in our previous communication,14a we 
began our investigation with the optimization of 
different reaction parameters such as catalyst, 
temperature, concentration, acid additive or solvent 
using ketoaldehyde 2a as model substrate for the 
cyclization (Scheme 3). 
 
Scheme 3 Model reaction. 
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In an initial screening of different chiral secondary 
amines as organocatalysts (I-VIII, Scheme 3), the 
steric bulk of the silyl and the aryl group were found 
to have a positive effect on the enantioselectivity of 
this process, however the use of very bulky catalysts 
resulted in poor reactivity. Thus, as a compromise 
between both reactivity and enantioselectivity, IV was 
identified as the most appropriate catalyst. We were 
also pleased to observe that the use of an acid additive 
such as acetic acid or benzoic acid,42 increased the 
reaction rate without affecting the enantioselectivity. 
After a study of different solvents and reaction 
temperatures, the best results were obtained in 
dichloromethane at room temperature. Other 
experiments, including the addition of H2O, variation 
of the concentration, or slow addition of a solution of 
the starting material to the reaction mixture using a 
syringe pump, did not lead to any improvement. We 
then extended the method to several substrates and we 
also demonstrated its applicability carrying out an 
enantioselective synthesis of (R)-rotundial (Figure 
2),14a a potent natural mosquito repellent isolated from 
the plant Vitex rotundifolia.43 To the best of our 
knowledge this constituted the first organocatalytic 
enantioselective synthesis of (R)-rotundial in 25% 
overall yield, after 6 steps, and with good 
enantioselectivity (86% ee).44 
2 Organocatalytic Cyclization of Tethered ,-
Unsaturated Carbonyl Compounds  
Synthesis of Cyclopentene Derivatives 
 
Furthermore, we investigated the scope of the 
cyclization under the optimized reaction conditions 
[IV · AcOH (20 mol%), CH2Cl2, r.t.], furnishing the 
corresponding derivatives 1a-m in good yields and 
high enantioselectivities (Scheme 4),45 starting from 
an extended set of substrates 2a-m that was derived 
from double homologation of dialdehydes such as 
succinaldehyde or from commercially available 
sources such as geranyl acetate. 
 
Scheme 4 Substrate scope. [a] Results published in our previous communication.14a [b] After one recrystallization.
These results clearly demonstrate the flexibility of our 
methodology for introducing differently substituted 
carbonyl compounds such as aldehydes, aliphatic 
ketones, electron rich and electron poor aromatic 
ketones, and other groups such as nitroalkenes. We 
noted that the electronic properties at the RC acceptor 
strongly influence the reaction rate and the 
enantioselectivity of this process. Higher reaction 
rates can be achieved using Michael acceptors bearing 
substituents with electron-withdrawing groups (1k-m) 
whereas significantly lower reaction rates were 
observed with electron-donating substituents (1i).14a 
The use of ,-unsaturated alkyl ketones as RC 
acceptor affords the final adduct in high 
enantioselectivity with moderate to good yield (1a,g), 
unfortunately bulkier alkyl groups such as tBu (1h) 
lead to a lower yield but with good enantioselectivity. 
It was possible to employ another Michael acceptor 
4   
  page 4 of 14 
such as nitroalkenes but the reaction proceeded with 
lower enantioselectivity (1j).14a In general, we have 
observed that prolonged reaction times led to reduced 
yields. In this respect, the formation of by-products is 
the major cause for that reduction, and may be 
attributed to the instability of aldehyde group. 
Interestingly, when the substrate lacks a methyl group 
in the -position of the RC donor aldehyde (1b,d,f), 
the results are inferior. Thus, the presence of this 
methyl group appears to be critical for the success of 
the process, in terms of both reactivity and 
enantioselectivity. Therefore and as previously 
suggested, the methyl group should play an important 
role in the mechanism of the reaction. 
The absolute configuration of the product was 
determined to be R by comparison of the optical 
rotation of rotundial (1c) with that reported in the 
literature,44 and further confirmed by X-ray analysis of 
compound 1m.14a The R configuration of the 
stereogenic center created by the dienamine catalysis 
was established and assumed for all products obtained 
(1a-m). 
2.1 Mechanistic Proposal 
In our previous report, we proposed the catalytic cycle 
shown in Scheme 5.14a The first step is the 
condensation of the substrate 2 with the catalyst IV.46 
The resulting iminium ion 3 possibly exists in an 
equilibrium with the dienamines 4 and 4’.13b,47 In this 
case, the reaction is completely -selective, probably 
due to steric reasons. The dienamine reacts as an 
enamine adding to the RC acceptor in an 
intramolecular Michael reaction leading to 
intermediate 5. It is worth mentioning that a 
mechanism proceeding through a [4+2]-cycloaddition 
of a dienamine intermediate was proposed by Boland 
for the biosynthesis of chrysomelidial and plagiodial 
as depicted in Scheme 2,41 and can be not ruled out 
completely in this case, although the corresponding 
bicyclic intermediate 9 has not been detected in our 
process (Scheme 5). Traces of compound 8 resulting 
from the hydrolysis of intermediate 5, have been 
observed by 1H NMR.48 It should be noted that each 
step in the catalytic cycle is reversible and proton 
abstraction (5 → 6) and reprotonation (6 → 5) could 
easily lead to trans-5. Presumably, hydrolysis of 5 to 8 
is slow; therefore, protonation of 6 in the -position 
leads to iminium ion 7, and final hydrolysis releases 
the product 1 and regenerates the catalyst IV. 
 
Scheme 5 Mechanistic hypothesis.
Based on our mechanistic proposal, we hypothesized 
that the -methyl substituent in intermediate 4 could 
lower the relative energy of the required 3Z-configu-
ration and its E-isomer for the following cyclization 
step (Scheme 5). In contrast, competitive side 
reactions, at the -position, could take place in 
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absence of the methyl group, explaining the poor yield 
obtained for these substrates (2b,d,f). Moreover, the 
more favorable 3E-dienamine configuration cannot 
engage in the cyclization step. 
In order to show that the double bond configuration in 
the enal starting material 2 is inconsequential for the 
selectivity of the reaction, an experiment with 
compound 2Z-2a was performed (Scheme 6). In this 
case, the same absolute configuration of compound 1a 
was obtained as the major one, with a similar yield in 
comparison with the experiment carried out with E-
isomer (3 h, 53%, 94% ee vs 5 h, 63%, 91% ee). This 
observation could be explained if we assume that the 
2Z-isomer and the 2E-isomer converge into the same 
dienamine 4 (Scheme 5). 
 
Scheme 6 Studying the influence of the double bond configuration 
of the enal starting material. 
In order to support our mechanistic model and some 
of the proposed intermediates, we carried out HRMS 
and deuterium labeling experiments. 
2.1.1 ESI-HRMS Measurements 
We performed ESI-HRMS measurements using 
mixtures of aldehyde 2m and catalyst IV in order to 
find evidence for intermediates where the catalyst is 
covalently bound to the substrate.49 We could identify 
some mass peaks corresponding to different species 
involved in the mechanistic proposal in Scheme 5, 
such as the starting material 2m (m/z 263), the final 
product 1m (m/z 263), and the catalyst IV (m/z 326), 
as well as other intermediates in the catalytic cycle, all 
with the same mass, for example 4m and 4’m (m/z 
570) (Figure 3). We were not able to detect 
intermediate 10 corresponding to the double 
condensation of the catalyst with both carbonyl 
groups.50 This fact was expected due to the low 
tendency for catalyst IV to activate the hindered 
ketone moiety.3 However, absence of evidence is not 
evidence of absence and thus the existence of such a 
possibly short-lived intermediate cannot be ruled out. 
Interestingly, the mass of the corresponding 
oxazolidine 11 (hemiaminal between substrate 2m and 
catalyst IV) was found (m/z 498), which is formed in 
situ after cleavage of the TMS group of the catalyst 
IV to give the free alcohol 12, detected also by HRMS 
(m/z 254) (Figure 4). This would explain the relatively 
high catalyst loading required (20 mol%), for this 
process. The measured and calculated high resolution 
masses of the species are given in Table 1. These 
results support the reactive species given in our 
mechanistic hypothesis. 
 
Figure 3 ESI-HRMS spectrum of the crude reaction mixture after five minutes.
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Figure 4 Oxazolidine 11 and alcohol free catalyst 12. 
Table 1 HRMS (ESI) analysis of the detected intermediates. 
Species Mass 
(calcd) 
Mass 
(found) 
Formula Error 
(ppm) 
[2m+H]+ 
[1m+H]+ 263.08333 263.08351 C15H16O2Cl 0.68311 
[IV+H]+ 326.19347 326.19369 C20H28ONSi 0.66807 
[4m+H]+ 570.25896 570.25824 C35H41O2NClSi 1.26884 
[11+H]+ 498.21943 498.21906 C32H33O2NCl 
[12+H]+ 254.15394 254.15424 C17H20ON 
 
2.1.2 NMR Experiments 
In order to gain further evidence for the intermediacy 
of the dienamines 4 and 4’, we performed an NMR 
experiment, examining the incorporation of deuterium 
into the final adduct 1l. First, the cyclization 
experiment of 2l was performed using deuterated 
solvent (CD2Cl2) and acid (AcOD), and 1 equiv. of 
D2O (Scheme 7). Then, incorporation of deuterium 
was observed at positions (a-c) into the final product 
1l by 2H NMR (CHCl3, 500 MHz), as illustrated in 
Figure 5. 
 
Scheme 7 Cyclization of 2l in CD2Cl2 and the presence of D2O and 
AcOD. 
In the 2H NMR spectrum, we could observe the 
incorporation of deuterium in the positions a and b 
which is in agreement with the formation of the two 
dienamines 4 and 4’ as proposed in our mechanistic 
hypothesis. The observed deuterium incorporation in 
position c is a consequence of the deuteration of the 
enol 5 to give ketone 6 or a subsequent 
tautomerization (Scheme 5). 
 
Figure 5 1H and 2H NMR spectra of compound d3-1l.
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2.1.3 Complementary Reactivity 
It is interesting to compare the reactivity profile of our 
RC-type reaction with classical RC reactions using 
nucleophilic phosphines, as previously described by 
Krische and Roush in 2002 (Scheme 8).24,25 
 
Scheme 8 RauhutCurrier reaction catalyzed by PMe3. 
When we applied our optimized conditions to 
substrate 2a (route a, Scheme 9), we only observed 
the formation of compound 1a in good yield and 
enantioselectivity. However, with the conditions of 
Roush (route b, Scheme 9), a complex mixture of 
products was obtained. While compound 1a was 
isolated in only 3% yield, instead 1a’ (6%) was the 
major product, that was prone to the formation of 
bicyclic follow-up products 11 (8%) and 12 (8%). 
 
Scheme 9 Aminocatalysis vs PMe3 as organocatalyst in the 
cyclization of compound 2a. 
This behavior can be explained with the classical RC 
activation, which is initiated by a 1,4-addition of the 
phosphine catalyst (Scheme 10). Due to steric and 
electronic effects, the -substituted aldehyde appears 
to be less electrophilic than the unsubstituted ,-
unsaturated ketone. In this sense the presence of the 
methyl group in the structure would direct the initial 
attack in each case affording complementary 
chemoselectivity. The mechanism explaining the 
formation of product 1a’ is depicted in Scheme 10 and 
is in agreement with the expected RauhutCurrier 
mechanism using phosphines as catalysts. The 
products 13 and 14 are believed to result from an 
intramolecular aldol addition/elimination. 
 
Scheme 10 Proposed mechanism for the formation of 1a’. 
2.2 Synthetic Applications 
In order to showcase the synthetic utility of this 
strategy, we embarked on the synthesis of the iridoid, 
mitsugashiwalactone (17), as we did previously using 
this method for the synthesis of rotundial (1c).14a 
The synthesis of ()-mitsugashiwalactone (17)51 was 
accomplished from dialdehyde 1d. After reduction to 
the diol 18,52 and oxidation to lactone 19, the final 
product was obtained by a 1,4-addition of methyl 
cuprate (Scheme 11).53 Unfortunately, the product 
could not be obtained with high enantiomeric excess. 
It should be noticed that enantioselectivity dropped to 
10% ee (from 43% ee) in the oxidation step of 18 to 
give 19. The low enantioselectivity in the formation of 
the cyclic precursor 1d was limiting the overall 
enantiomeric excess to 57% ee (Scheme 4). 
 
Scheme 11 Synthesis of ()-mitsugashiwalactone (17). 
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3 Organocatalytic Cyclization of Tethered ,-
Unsaturated Carbonyl Compounds  
Synthesis of Cyclohexene Derivatives 
We also studied the formation of six-membered rings, 
e.g. the trisubstituted cyclohexene derivatives 21a-b 
(Scheme 13). The synthesis of the required cyclization 
precursors (20a-b) is outlined in Scheme 12. 
Hydroxyaldehyde 24 was obtained from commercially 
available ketonitrile 22 by a HWE olefination 
followed by a Dibal-H reduction54 and subjected to a 
Wittig olefination with the respective phosphor-
anylidenes 25. After IBX oxidation of the allylic 
alcohols 26, ketoaldehydes 20a-b were obtained. 
 
Scheme 12 Synthesis of the substrates 20a-b. 
Unfortunately, when the substrates 20a-b were 
submitted to the conditions that were optimized for 
the formation of corresponding five-membered rings, 
only poor yields (7-9%) were obtained albeit with 
good enantioselectivities (76-82% ee) (Scheme 13).45 
Me IV AcOH
(20 mol%)
CH2Cl2, r.t.
O
O
X20a X = NO2
20b X = Cl
21a
(9% yield, 76% ee)
21b
(7% yield, 82% ee)
O
O
X
Me
 
Scheme 13 Organocatalytic enantioselective cyclization of 20a-b. 
The lower reaction rates observed in the cyclization 
reactions leading to 6-membered rings, as well as the 
poor yields, may be explained with competing 
decomposition of the starting material. Interestingly, 
in this instance we have been able to detect significant 
amounts of a non-conjugated cyclic product 27 from 
which we obtained single crystals (Figure 6). An X-
ray analysis revealed the relative configuration to be 
trans.55,56 This finding provides further support for the 
intermediacy of the elusive intermediates 5 and 8 from 
the cyclopentene series (Scheme 5). 
 
Figure 6 X-Ray structure of non-conjugated product 27. 
4 Conclusions 
In summary, we have provided new results and 
mechanistic studies for a better understanding of the 
enantioselective RauhutCurrier-type reaction. We 
have investigated the cyclization of different 
substrates using dienamine activation affording 
cyclopentene derivatives in good yields and moderate 
to high enantioselectivities. The analysis of 
experiments such as ESI-HRMS or 2H NMR, supports 
the proposed mechanism and reveals the importance 
of the methyl group in the β-carbon of the explored 
substrates. Our procedure represents a useful tool for 
the asymmetric synthesis of highly functionalized 
cyclopentenes, such as iridoid derivatives as 
biologically important targets. The formation of 
cyclohexene derivatives has been observed but leaves 
room for further optimization.  
All commercially available solvents and reagents were 
used as received. Analytical thin layer 
chromatography was performed on Merck TLC silica 
gel 60 F254. Purification of reaction products was 
carried out by flash chromatography using silica gel 
(0.0400.063 mm). NMR spectra were recorded on 
Bruker DPX300 (300 MHz), DRX400 (400 MHz) or 
DRX500 (500 MHz) spectrometers. Chemical shifts 
were reported in the  scale relative to residual solvent 
peaks [CHCl3: δ 7.26 ppm (1H NMR) and 77.16 ppm 
(13C NMR), CD3COCD3: δ 2.05 ppm (1H NMR) and 
206.26 ppm (13C NMR) and CD3OD: δ 3.31 ppm 
(1H NMR) and 49.00 ppm (13C NMR)]. Chiral HPLC 
analysis was performed using an Agilent 1200 series 
HPLC with a diode array detector. Chiral columns 
include Daicel Chiralpak IA and IB.57 
Experimental Procedure for Cyclization of 
Compounds 2 and 20 
In a test tube, to a stirring solution of catalyst (S)-IV 
(20 mol%) and acetic acid (20 mol%) in CH2Cl2 
(1 mL), a solution of 257 or 2057 in CH2Cl2 (2 mL) was 
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added dropwise, and stirred at r.t. until consumption 
of the starting material (TLC). Then a saturated 
aqueous solution of NaHCO3 (2 mL) was added and 
the aqueous phase was extracted with CH2Cl2 (2 x 
2 mL) and Et2O (2 x 2 mL). The combined organic 
phases were dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure after 
filtration. The crude product was purified by column 
chromatography on silica gel affording products 1 or 
21.58 The reaction times, yields, and spectral and 
analytical data for 1 and 21 are as follows. 
Organocatalytic Cyclization of 2  Five Membered 
Rings 
(R)-5-(2-Oxopropyl)cyclopent-1-enecarbaldehyde 
(1b) 
Following the general procedure starting from 2b 
(54.79 mg, 0.36 mmol), after 25 h of reaction, 1b25a 
was obtained as yellow oil in 8% yield (4.32 mg), 
after column chromatography (SiO2, pentane/Et2O 8:1  4:1), 66% ee. 
HPLC conditions: Daicel Chiralpak IA column 
(hexane/i-PrOH 95:5, flow rate 0.5 mL/min, UV 254.0 
nm, minor = 17.4 min; major = 20.2 min). 
[]D24 +27.1 (c = 0.33, CHCl3, 66% ee). 
(R)-5-(2-Oxoethyl)cyclopent-1-enecarbaldehyde 
(1d) 
Following the general procedure starting from 2d 
(55.00 mg, 0.40 mmol), after 22 h of reaction, 1d was 
obtained as colorless oil in 23% yield (12.61 mg) after 
column chromatography (SiO2, pentane/Et2O 8:1  
1:1), 57% ee (after derivatization).57 
IR (KBr film) (cm1)  3020, 2926, 1722, 1677, 1493, 
1453, 1216, 754, 669. 
1H NMR (400 MHz, CD3COCD3):  9.77 (s, 1H), 
9.74 (t, J = 1.5 Hz, 1H), 7.06-7.04 (m, 1H), 3.34 (br s, 
1H), 2.86 (ddd, J = 17.1, 4.5, 1.5 Hz, 1H), 2.70-2.50 
(m, 2H), 2.41 (ddd, J = 17.1, 9.0, 2.0 Hz, 1H), 2.34-
2.24 (m, 1H), 1.70-1.62 (m, 1H). 
13C NMR (100 MHz, CD3COCD3):  202.0, 190.3, 
155.2, 149.6, 48.2, 37.4, 32.7, 31.0. 
GC-EI-MS m/z (%) 67 (92), 81 (75), 94 (100), 120 
(50), 138 (3) [M]+. 
GC-EI-HRMS ([M]+) calcd for C8H10O2 138.0671, 
found 138.0675. 
(R)-5-(2-Oxo-2-phenylethyl)cyclopent-1-
enecarbaldehyde (1f) 
Following the general procedure starting from 2f 
(77.13 mg, 0.36 mmol), after 22 h of reaction, 1f was 
obtained as yellow oil in 20% yield (15.43 mg) after 
column chromatography (SiO2, pentane/Et2O 8:1), 
51% ee. 
HPLC conditions: Daicel Chiralpak IA column 
(hexane/i-PrOH 90:10, flow rate 0.5 mL/min, UV 
254.0 nm, minor = 15.9 min; major = 17.8 min). 
[]D24 +44.6 (c = 1.30, CHCl3, 51% ee). 
IR (KBr film) (cm1)  2937, 2812, 1677, 1448, 1363, 
1282, 1202, 984, 753, 692. 
1H NMR (400 MHz, CDCl3):  9.81 (s, 1H), 8.00-7.98 
(m, 2H) 7.57-7.53 (m, 1H), 7.47-7.44 (m, 2H), 6.94-
6.92 (m, 1H), 3.72 (dd, J = 16.5, 3.0 Hz, 1H), 3.54 (br 
s, 1H), 2.75 (dd, J = 16.5, 10.5 Hz, 1H), 2.71-2.51 (m, 
2H), 2.39-2.30 (m, 1H), 1.77-1.69 (m, 1H). 
13C NMR (100 MHz, CDCl3):  199.4, 190.0, 154.8, 
149.2, 136.9, 133.2, 128.7, 128.3, 42.3, 38.7, 32.4, 
30.3. 
GC-EI-MS m/z (%) 77 (40), 105 (100), 214 (8) [M]+. 
HPLC-EI-HRMS ([M]+) calcd for C14H14O2 214.0988, 
found 214.0985. 
(R)-2-Methyl-5-(2-(4-nitrophenyl)-2-
oxoethyl)cyclopent-1-enecarbaldehyde (1g) 
Following the general procedure starting from 2g 
(130 mg, 0.72 mmol), after 9 h of reaction, 1g was 
obtained as yellow oil in 62% yield (70.00 mg) after 
column chromatography (SiO2, cyclohexane/EtOAc 
3:1), 85% ee. 
HPLC conditions: Daicel Chiralpak IA column 
(hexane/i-PrOH 90:10, flow rate 0.5 mL/min, UV 
254.4 nm, minor = 17.0 min; major = 15.1 min). 
[]D20 +109.7 (c = 1.0, CHCl3). 
IR (KBr) (cm1)  2975, 2939, 2834, 2757, 1712, 
1664, 1631, 1433, 1411, 1378, 1350, 1272, 1190, 
1114, 1032, 977, 761, 584, 421. 
1H NMR (400 MHz, CDCl3):  9.97 (s, 1H), 3.41 (br 
s, 1H), 3.00 (dd, J = 1.6, 0.4 Hz, 1H), 2.63-2.55 (m, 
1H), 2.51-2.32 (m, 3H), 2.28 (dd, J = 16.7, 10.1 Hz, 
1H), 2.19-2.10 (m, 1H), 2.13 (s, 3H), 1.53-1.45 (m, 
1H), 1.05 (t, J = 0.8 Hz, 3H). 
13C NMR (400 MHz, CDCl3):  210.9, 188.1, 164.0, 
139.5, 46.0, 39.5, 39.0, 35.9, 28.2, 14.4, 7.8. 
HPLC-ESI-HRMS ([M+H]+) calcd for C11H17O2 
181.25148, found 181.12223. 
(R)-2-Methyl-5-(2-(4-nitrophenyl)-2-
oxoethyl)cyclopent-1-enecarbaldehyde (1h) 
Following the general procedure starting from 2h 
(70.71 mg, 0.34 mmol), after 25 h of reaction, 1h was 
obtained in 38% yield (27 mg) after column 
chromatography (SiO2, pentane/Et2O 4:1), 75% ee. 
HPLC conditions: Daicel Chiralpak IA column 
(hexane/i-PrOH 97:3, flow rate 0.5 mL/min, UV 
254.4 nm, minor = 13.4 min; major = 15.2 min). 
[]D20 +92.7 (c = 1.03, CHCl3). 
IR (KBr) (cm1)  2968, 1704, 1662, 1478, 1394, 
3380, 1366, 1345, 1283, 1250, 1188, 1063, 1002. 
1H NMR (400 MHz, CDCl3): 9.98 (s, 1H), 3.41 (br 
s, 1H), 3.07 (dd, J = 2.0, 0.4 Hz, 1H), 2.62-2.53 (m, 
1H), 2.50-2.37 (m, 2H), 2.22-2.15 (m, 1H), 2.14 (s, 
3H), 1.42-1.34 (m, 1H), 1.11 (s, 9H). 
13C NMR (400 MHz, CDCl3):  215.2, 188.2, 163.9, 
139.8, 44.0, 40.3, 39.4, 39.1, 28.4, 26.4 (3C), 14.5. 
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HPLC-ESI-HRMS ([M+H]+) calcd for C13H21O2 
209.30464, found 209.15361. 
Cyclization of 2a Using PMe3 as Organocatalyst 
A solution of (2E,6Z)-3-methyl-8-oxonona-2,6-dienal 
(2a) (59.83 mg, 0.36 mmol) in tert-amyl alcohol 
(3.6 mL) was deoxygenated by bubbling Ar through 
the solution for 30 min. To the oxygen-free solution 
was added PMe3 (7.8 L, 0.07 mmol) by syringe.25a 
After 1 h the reaction mixture was treated with an 
aqueous solution of NaHSO4 (1 M). Then the organic 
layer was separated and the aqueous layer was 
extracted with Et2O (3 x 2 mL). The combined organic 
phases were washed with an aqueous saturated 
solution of NaCl, dried over anhydrous Na2SO4 and 
the solvent was removed under reduced pressure after 
filtration. The crude product was purified by column 
chromatography (SiO2, pentane/Et2O 8:1  1:2) 
affording products 1a (3%), 1a’ (6%), 13 (8%) and 14 
(8%). The spectral and analytical data for 1a’, 13 and 
14 are as follows. 
2-(2-Acetyl-1-methylcyclopent-2-enyl)acetaldehyde 
(1a’)  
Yellow oil. 
IR (KBr film) (cm1)  3440, 2930, 1708, 1665, 1365, 
1264, 1102. 
1H NMR (500 MHz, CDCl3):  9.69 (dd, J = 3.2, 1.9 
Hz, 1H), 6.76 (t, J = 2.8 Hz, 1H), 2.87 (dd, J = 15.4, 
1.9 Hz, 1H), 2.70 (dd, J = 15.5, 3.1 Hz, 1H), 2.53-2.45 
(m, 2H), 2.30 (s, 3H), 1.99 (ddd, J = 13.0, 8.6, 7.4 Hz, 
1H), 1.83 (ddd, J = 13.2, 8.2, 5.0 Hz, 1H), 1.30 (s, 
3H). 
13C NMR (125 MHz, CDCl3):  202.9, 196.9, 149.7, 
145.9, 52.6, 47.1, 38.2, 30.5, 27.7, 26.1. 
GC-EI-MS m/z (%) 122 (100), 138 (70), 151 (10), 166 
(3) [M]+. 
GC-EI-HRMS ([M]+) calcd for C10H14O2 166.0988, 
found 166.0986. 
6-Hydroxy-7a-methyl-5,6,7,7a-tetrahydro-1H-
inden-4(2H)-one (13) 
Yellow oil. 
IR (KBr film) (cm1)  3430, 2931, 1774, 1617, 1253, 
1151, 1044. 
1H NMR (500 MHz, CDCl3):  6.51 (t, J = 2.7 Hz, 
1H), 4.35-4.28 (m, 1H), 2.87 (ddd, J = 16.7, 5.3, 2.1 
Hz, 1H), 2.59-2.49 (m, 1H), 2.47-2.38 (m, 1H), 2.33-
2.20 (m, 2H), 2.03-1.95 (m, 1H), 1.92-1.84 (m, 1H), 
1.64-1.60 (m, 2H), 1.08 (s, 3 H). 
13C NMR (125 MHz, CDCl3):  197.1, 148.0, 137.2, 
66.6, 50.1, 47.6, 45.6, 42.4, 30.4, 25.1. 
GC-EI-HRMS ([M]+) calcd for C10H14O2 166.0988, 
found 166.0993. 
7a-Methyl-7,7a-dihydro-1H-inden-4(2H)-one (14) 
Yellow oil. 
IR (KBr film) (cm1)  3447, 2960, 2926, 1688, 1455, 
1382, 1261, 1098, 1024. 
1H NMR (400 MHz, CDCl3):  6.89 (ddd, J = 10.3, 
6.0, 2.3 Hz, 1H), 6.65 (t, J = 2.8 Hz, 1H), 6.12 (ddd, J 
= 10.0, 3.0, 1.0 Hz, 1H), 2.60-2.32 (m, 4H), 2.05 (ddd, 
J = 12.5, 6.0, 2.5 Hz, 1H), 1.88 (dt, J = 12.5, 9.5 Hz, 
1H), 1.12 (s, 3H). 
13C NMR (125 MHz, CDCl3):  186.8, 148.5, 146.9, 
137.0, 130.5, 46.9, 41.5, 41.2, 30.3, 25.0. 
ESI-MS m/z (%) 149 (100) [M+1]+. 
GC-EI-HRMS ([M]+) calcd for C10H12O 148.0883, 
found 148.0875. 
Syntesis of ()-Mitsugashiwalactone (17) 
(R)-4,4a,5,6-Tetrahydrocyclopenta[c]pyran-1(3H)-
one (19)52a,59 
MnO2 (1.75 g, 20.13 mmol) was added to a solution 
of diol 18 (159 mg, 1.12 mmol, 43% ee (after 
derivatization)57 in CHCl3 (5 mL). The resulting 
mixture was stirred at 66 ºC for 12 h, and then filtered. 
The solvent was removed under reduced pressure. The 
crude product was purified by column 
chromatography (SiO2, pentane/EtOAc 3:1) to afford 
lactone 1951b in 71% yield (110 mg) as a light yellow 
oil. 
[]D22 = 12.1 (c = 1.00, CHCl3, 10% ee) {lit.51b 
[]D31 = 116.6 (c = 0.93, CHCl3, >99% ee (HPLC))}. 
IR (KBr film) (cm1)  1715, 1628, 1255, 743. 
1H NMR (400 MHz, CDCl3):  6.99 (d, J = 2.5 Hz, 
1H), 4.45 (ddd, J = 11.6, 4.5, 2.0 Hz, 1H), 4.31 (dt, J 
= 11.5, 2.5 Hz, 1H), 2.97 (br s, 1H), 2.50-2.45 (m, 
2H), 2.41-2.34 (m, 1H), 2.10 (br dt, J = 13.5, 2.5 Hz, 
1H), 1.73-1.58 (m, 2H). 
13C NMR (100 MHz, CDCl3):  163.5, 145.5, 134.7, 
69.7, 42.0, 32.7, 31.7, 30.8. 
ESI-MS m/z (%) 93 (27), 111 (33), 139 (100) [M+H]+. 
HPLC-EI-HRMS ([M+H]+) calcd for C8H11O2 
139.07536, found 139.07509. 
(4aR,7S,7aR)-7-
Methylhexahydrocyclopenta[c]pyran-1(3H)-one 
(17)51b 
To a solution of lithium dimethylcuprate [prepared in 
situ by mixing CuI (310 mg, 1.63 mmol) in Et2O 
(2 mL) and MeLi in Et2O (2.14 mL, 3.26 mmol, 1.6 M 
in Et2O) at 25 ºC], lactone 19 (75 mg, 0.54 mmol) in 
Et2O (1 mL) was added at 25 ºC and stirring at the 
same temperature for 30 min. Then a saturated 
aqueous solution of NH4Cl was added, and the 
mixture was extracted with Et2O (3 x 7 mL). The 
combined organic phases were washed with brine 
(2 mL), dried over anhydrous MgSO4 and the solvent 
was removed under reduced pressure after filtration. 
The crude product was purified by column 
chromatography (SiO2, pentane/EtOAc 4:1) to afford 
() mitsugashiwalactone (17)51 in 84% yield (70 mg) 
as colorless oil. 
11   
  page 11 of 14 
[]D20 = 0.6 (c = 2.00, CHCl3) {lit.51b []D32 = .3 
(c = 0.92, CHCl3), []D32 = .3 (c = 0.96, CCl4), 
[]D24 = .6 (c = 2.00, CHCl3), natural51a []D32 = .4 (not described)}. 
IR (KBr film) (cm1)  3018, 2956, 2926, 2856, 1723, 
1216, 756. 
1H NMR (400 MHz, CDCl3):  4.33 (ddd, J = 11.1, 
6.6, 3.0 Hz, 1H), 4.20 (ddd, J = 11.0, 8.5, 2.5 Hz, 1H), 
2.59-2.54 (m, 1H), 2.38 (t, J = 9.6 Hz, 1H), 2.26-2.20 
(m, 1H), 2.04-2.00 (m, 2H), 1.94-1.90 (m, 1H), 1.57-
1.50 (m, 1H), 1.33-1.18 (m, 2H), 1.21 (d, J = 6.5 Hz, 
3H). 
13C NMR (100 MHz, CDCl3):  174.6, 66.9, 50.2, 
39.5, 36.2, 34.7, 32.7, 29.2, 19.9. 
ESI-MS m/z (%) 109 (55), 155 (100) [M+H]+. 
HPLC-EI-HRMS ([M+H]+) calcd for C9H15O2 
155.10666, found 155.10635. 
Organocatalytic Cyclization of 20  Six Membered 
Rings 
Following the general procedure starting from 20a 
(114.90 mg, 0.04 mmol), after 48 h of reaction, 
products 21a (9% yield, 76% ee) and 27 (12% yield, 
>99% ee) were obtained after column chromatography 
(SiO2, pentane/Et2O 4:1  2:1); (21a:27 = 24:76, by 
1H NMR of the crude product). 
2-Methyl-6-(2-(4-nitrophenyl)-2-oxoethyl)cyclohex-
1-enecarbaldehyde (21a) 
HPLC conditions: Daicel Chiralpak IA column 
(hexane/i-PrOH 90:10, flow rate 1.0 mL/min, UV 
254.4 nm, major = 20.4 min; minor = 24.2 min). 
1H NMR (400 MHz, CDCl3):  10.17 (s, 1H), 8.39-
8.24 (m, 4H), 3.36 (dd, J = 14.6, 3.0 Hz, 1H), 3.25-
3.20 (m, 1H), 2.68 (dd, J = 14.6, 11.0 Hz, 1H), 2.31-
2.24 (m, 2H), 2.20 (s, 3H), 1.77-1.63 (m, 3H), 1.56-
1.48 (m, 1H). 
13C NMR (125 MHz, CDCl3):  198.5, 191.0, 159.1, 
150.5, 141.2, 136.0, 129.8, 124.0, 43.2, 34.5, 28.7, 
25.6, 18.9, 17.4. 
EI-MS m/z (%) 94 (100), 150 (80), 259 (85), 270 (50), 
287 (10) [M]+. 
GC-EI-HRMS ([M]+) calcd for C16H17O4N 287.1152, 
found 287.1151. 
2-Methyl-6-(2-(4-nitrophenyl)-2-oxoethyl)cyclohex-
2-enecarbaldehyde (27) 
HPLC conditions: Daicel Chiralpak IB column 
(hexane/i-PrOH 80:20, flow rate 0.5 mL/min, UV 
254.4 nm, major = 20.6 min; minor = 25.0 min). 
1H NMR (400 MHz, CDCl3):  9.58 (d, J = 2.9 Hz, 
1H), 8.32 (d, J = 8.8 Hz, 2H), 8.10 (d, J = 8.8 Hz, 
2H), 5.77 (br s, 1H), 3.09 (dd, J = 17.6, 6.5 Hz, 1H), 
2.99 (dd, J = 17.6, 6.5 Hz, 1H), 2.85-2.77 (m, 1H), 
2.72 (br s, 1H), 2.13-2.07 (m, 2H), 1.82-1.74 (m, 1H), 
1.73 (br s, 3H), 1.50-1.37 (m, 1H). 
EI-MS m/z (%) 94 (100), 150 (80), 259 (85), 270 (40), 
287 (10) [M]+. 
GC-EI-HRMS ([M]+) calcd for C16H17O4N 287.1152, 
found 287.1150. 
6-(2-(4-Chlorophenyl)-2-oxoethyl)-2-
methylcyclohex-1-enecarbaldehyde (21b) 
Following the general procedure starting from 20b 
(52.4 mg, 0.19 mmol), 21b was obtained after 3 d in 
7% yield (3.51 mg) after column chromatography 
(SiO2, pentane/Et2O 6:1), 82% ee. 
HPLC conditions: Daicel Chiralpak IA column 
(hexane/i-PrOH 90:10, flow rate 0.5 mL/min, UV 
254.4 nm, minor = 19.6 min; major = 22.8 min). 
1H NMR (400 MHz, CDCl3): 10.17 (s, 1H), 8.08 (d, 
J = 8.5 Hz, 2H), 7.45 (d, J = 8.5 Hz, 2H), 3.30 (dd, J = 
14.7, 3.0 Hz, 1H), 3.25-3.20 (m, 1H), 2.60 (dd, J = 
14.7, 11.2 Hz, 1H), 2.27-2.24 (m, 2H), 2.19 (s, 3H), 
1.79-1.53 (m, 3H), 1.54-1.40 (m, 1H). 
13C NMR (125 MHz, CDCl3):  198.9, 191.0, 158.6, 
139.5, 136.4, 135.2, 130.2, 129.0, 42.6, 34.5, 28.8, 
25.5, 18.8, 17.4. 
HPLC-ESI-HRMS ([M+H]+) calcd for C16H18O2Cl 
277.09898, found 277.09917. 
Supporting Information for this article is available 
online at http://www.thieme-
connect.com/ejournals/toc/synthesis. 
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